The government’s new National Cancer Plan sets ambitious targets on early diagnosis and waiting times, with a significant share of new diagnostic capacity expected to come from the independent sector. IHPN CEO David Hare discusses the implications and steps required to make genuine progress Following Lord Darzi’s 2024 independent report into the NHS which concluded…
Membership Required
You must be a HM Subscriber to view this content.
Already have an account? Sign In
©2026 All rights reserved LaingBuisson
